XML 40 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity/(Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
Series A Preferred Stock
Series D Preferred Stock
Convertible Preferred Stock
Convertible Preferred Stock
Series D One Warrants
Convertible Preferred Stock
Series G Preferred Stock
Convertible Preferred Stock
Series A Preferred Stock
Convertible Preferred Stock
Series D Preferred Stock
Convertible Preferred Stock
Series H Preferred Stock
Class A and Class B Common Stock
Class A and Class B Common Stock
Series A Preferred Stock
Class A and Class B Common Stock
Series D Preferred Stock
Additional Paid-In Capital
Additional Paid-In Capital
Series A Preferred Stock
Additional Paid-In Capital
Series D Preferred Stock
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Non- controlling Interest
Beginning balance (in shares) at Dec. 31, 2018       324,304                            
Beginning balance at Dec. 31, 2018       $ 187,191                            
Ending balance (in shares) at Dec. 31, 2019       324,304                            
Ending balance at Dec. 31, 2019       $ 187,191                            
Balance beginning (Shares) at Dec. 31, 2018                   157,873                
Balance beginning at Dec. 31, 2018 $ (113,189)                 $ 16     $ 54,871     $ (8) $ (168,068) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Issuance of common stock upon exercises of stock option (in shares) 8,895                 8,895                
Issuance of common stock upon exercises of stock options $ 3,185                 $ 1     3,184         0
Stock- based compensation 17,634                       17,634          
Others 41                             41    
Cumulative translation adjustments 12                             6   6
Capital contribution from minority interest holder 50,000                       25,500         24,500
Net loss (71,114)                               (70,968) (146)
Issuance of warrants in connection with intangible asset purchase 482                       482          
Balance ending (Shares) at Dec. 31, 2019                   166,768                
Balance ending at Dec. 31, 2019 $ (112,949)                 $ 17     101,671     39 (239,036) 24,360
Increase (Decrease) in Temporary Equity [Roll Forward]                                    
Issuance of preferred stock (in shares)           23,645                        
Issuance of preferred stock           $ 149,669                        
Issuance of Series D-1 warrants upon exercise of warrants for cash (in shares) [1]         1,573                          
Issuance of Series D-1 warrants upon exercise of warrants for cash [1]         $ 8,225                          
Conversion of preferred stock to common stock (in shares)             (11,642) (645)                    
Conversion of preferred stock to common stock             $ (233) $ (25)                    
Ending balance (in shares) at Dec. 31, 2020 337,235     337,235                            
Ending balance at Dec. 31, 2020       $ 344,827                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Issuance of common stock upon exercises of stock option (in shares) 20,590                                  
Issuance of common stock in connection with the acquisition of a business (in shares)                   933                
Issuance of common stock in connection with the acquisition of a business $ 35,203                       35,203          
Conversion of convertible preferred stock to common stock in connection with the direct listing (in shares)                     11,642 645            
Conversion of convertible preferred stock to common stock in connection with the direct listing   $ 233 $ 25               $ 1 $ 0   $ 232 $ 25      
Stock- based compensation 79,158                       79,158          
Others (33)                             (33)   0
Cumulative translation adjustments 168                             84   84
Net loss (257,691)                               (253,254) (4,437)
Issuance of common stock upon exercise of stock options and settlement of RSUs (in shares)                   20,871                
Issuance of common stock from asset purchase (in shares)                   80                
Issuance of common stock from asset purchase 2,854                       2,854          
Issuance of restricted stock awards granted in conjunction with a business combination (in shares)                   388                
Issuance of restricted stock awards granted in conjunction with a business combination 5,493                       5,493          
Balance ending (Shares) at Dec. 31, 2020                   201,327                
Balance ending at Dec. 31, 2020 $ (232,381)                 $ 20     239,792     90 (492,290) 20,007
Increase (Decrease) in Temporary Equity [Roll Forward]                                    
Issuance of preferred stock (in shares)                 11,889                  
Issuance of preferred stock                 $ 534,286                  
Conversion of preferred stock to common stock (in shares)       (349,124)                            
Conversion of preferred stock to common stock       $ (879,113)                            
Ending balance (in shares) at Dec. 31, 2021 349,124     0                            
Ending balance at Dec. 31, 2021       $ 0                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Issuance of common stock upon exercises of stock option (in shares) 33,373                 33,372                
Issuance of common stock upon exercises of stock options $ 65,242                 $ 3     65,284         (45)
Issuance of common stock in connection with the acquisition of a business (in shares)                   487                
Issuance of common stock in connection with the acquisition of a business 31,274                       31,274          
Issuance of common stock under Employee Stock Purchase Plan (in shares)                   191                
Issuance of common stock under Employee Stock Purchase Plan 11,268                       11,268          
Conversion of convertible preferred stock to common stock in connection with the direct listing (in shares)                   349,124                
Conversion of convertible preferred stock to common stock in connection with the direct listing 879,113                 $ 35     879,078          
Stock- based compensation 341,942                       341,942          
Release of restricted stock units (in shares)                   1,376                
Others (in shares)                   1                
Others 0                                 0
Cumulative translation adjustments (55)                             (28)   (27)
Net loss (503,480)                               (491,651) (11,829)
Issuance of common stock upon exercise of stock options and settlement of RSUs 15,158                 $ 2     15,156          
Balance ending (Shares) at Dec. 31, 2021                   585,878                
Balance ending at Dec. 31, 2021 $ 592,923                 $ 58     $ 1,568,638     $ 62 $ (983,941) $ 8,106
[1] Exercise of warrants for gross proceeds of $0.1 million and a reclassification of warrant liability fair market value of $8.1 million as of the exercise date